AEVIS VICTORIA SA (AEVS) Nine-Month EBITDA Rises 41.0% to CHF 41.6M

What happened

For the first nine months of 2026, Swiss Medical Network Holding reported EBITDA, a measure of operating earnings before interest, taxes, depreciation and amortisation, up 41.0% to CHF 41.6M. EBITDAR rose 17.3% to CHF 113.8M, while organic net revenue growth was 0.5%.

Confirmed

Global impact / market context

Earnings grew much faster than revenue, suggesting improved profitability rather than rapid expansion in sales. Higher healthcare operating cash flow and lower financing costs could leave more cash for operations, while the modest 0.5% organic revenue growth limits evidence of broad-based demand improvement.

Analyst inference

Stronger operating earnings and cash generation may improve the company’s ability to fund operations and meet borrowing costs, but organic revenue growth remained limited. Reduced financing charges could support future profit, although the article does not quantify the savings or show how much revenue growth will follow.

Analyst inference

What to watch

1. Watch subsequent reports for organic net revenue growth, which excludes the effect of newly consolidated Radiologia Ticino, to see whether sales growth broadens beyond 0.5%. Analyst inference
2. The company says the credit facility has an option for a further one-year extension; whether that option is exercised could affect the duration of financing availability. Proposed
3. Future disclosures on restructuring benefits expected in 2027 could show whether operating changes lift earnings further, while cash flow indicates whether that improvement converts into cash. Analyst inference

Evidence

• eqs-news.com